🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/04/2013 | 45,11 | 45,87 | 44,95 | 45,68 | +1,10% | 2,03% | 11.110.477 |
| 25/04/2013 | 45,75 | 45,80 | 45,11 | 45,18 | -1,25% | 1,50% | 16.702.081 |
| 24/04/2013 | 46,44 | 46,56 | 45,68 | 45,75 | -1,40% | 1,89% | 16.292.418 |
| 23/04/2013 | 45,75 | 46,47 | 45,73 | 46,40 | +1,48% | 1,61% | 18.500.868 |
| 22/04/2013 | 45,28 | 45,77 | 45,02 | 45,73 | +0,91% | 1,66% | 14.950.139 |
| 19/04/2013 | 44,71 | 45,31 | 44,52 | 45,31 | +2,00% | 1,77% | 13.315.154 |
| 18/04/2013 | 44,71 | 44,83 | 44,36 | 44,43 | -0,43% | 1,05% | 11.813.685 |
| 17/04/2013 | 44,58 | 44,76 | 44,28 | 44,62 | -0,43% | 1,07% | 12.342.506 |
| 16/04/2013 | 44,50 | 44,90 | 44,37 | 44,81 | +1,08% | 1,18% | 10.674.614 |
| 15/04/2013 | 44,74 | 45,32 | 44,33 | 44,33 | -1,38% | 2,22% | 16.083.970 |
| 12/04/2013 | 44,53 | 44,97 | 44,51 | 44,95 | -0,21% | 1,03% | 10.547.491 |
| 11/04/2013 | 44,54 | 45,33 | 44,54 | 45,05 | +0,79% | 1,78% | 18.379.719 |
| 10/04/2013 | 43,81 | 44,82 | 43,68 | 44,69 | +2,92% | 2,59% | 19.634.385 |
| 09/04/2013 | 43,64 | 43,84 | 43,26 | 43,43 | +0,07% | 1,31% | 11.108.066 |
| 08/04/2013 | 43,02 | 43,40 | 42,90 | 43,40 | +0,78% | 1,15% | 10.640.868 |
| 05/04/2013 | 42,98 | 43,16 | 42,83 | 43,06 | -0,42% | 0,75% | 13.206.372 |
| 04/04/2013 | 43,31 | 43,78 | 42,95 | 43,24 | -0,09% | 1,92% | 14.637.835 |
| 03/04/2013 | 42,94 | 44,05 | 42,94 | 43,28 | +1,00% | 2,58% | 27.114.066 |
| 02/04/2013 | 42,47 | 42,94 | 42,39 | 42,85 | +1,26% | 1,30% | 13.400.252 |
| 01/04/2013 | 41,98 | 42,34 | 41,77 | 42,32 | +0,34% | 1,36% | 10.377.191 |
| 28/03/2013 | 42,03 | 42,28 | 41,95 | 42,18 | +0,23% | 0,79% | 17.440.502 |
| 27/03/2013 | 42,11 | 42,22 | 41,90 | 42,08 | -0,65% | 0,77% | 11.497.503 |
| 26/03/2013 | 41,94 | 42,37 | 41,89 | 42,36 | +1,60% | 1,14% | 12.694.110 |
| 25/03/2013 | 41,94 | 41,98 | 41,52 | 41,69 | -0,48% | 1,11% | 13.746.721 |
| 22/03/2013 | 41,85 | 42,09 | 41,79 | 41,89 | +0,25% | 0,71% | 10.463.232 |
| 21/03/2013 | 42,01 | 42,16 | 41,76 | 41,78 | -0,75% | 0,95% | 12.476.021 |
| 20/03/2013 | 41,98 | 42,26 | 41,87 | 42,10 | +0,96% | 0,93% | 15.693.066 |
| 19/03/2013 | 41,70 | 41,83 | 41,60 | 41,70 | +0,16% | 0,55% | 16.248.297 |
| 18/03/2013 | 41,77 | 41,93 | 41,57 | 41,63 | -1,04% | 0,85% | 12.699.350 |
| 15/03/2013 | 41,82 | 42,07 | 41,78 | 42,07 | -0,41% | 0,68% | 25.499.831 |